US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 0.540
  • -0.011-2.01%
Close Feb 28 16:00 ET
  • 0.567
  • +0.027+5.00%
Post 20:01 ET
138.18MMarket Cap-3.23P/E (TTM)

About Adaptimmune Therapeutics Company

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Company Profile

SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2014
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000
Websitehttp://www.adaptimmune.com

Company Executives

  • Name
  • Position
  • Salary
  • Adrian Rawcliffe
  • Director and Chief Executive Officer
  • 2.77M
  • William C. Bertrand, Esq.,Jr
  • Chief Operating Officer
  • 1.22M
  • Dr. Elliot Norry
  • Chief Medical Officer
  • 1.18M
  • Dr. Helen Tayton-Martin, PhD
  • Chief Business and Strategy Officer
  • 1.18M
  • John Lunger
  • Chief Patient Supply Officer
  • --
  • Gavin Hilary James Wood
  • Chief Financial Officer and Principal Accounting Officer
  • 1.17M
  • Cintia Piccina
  • Chief Commercial Officer
  • --
  • Dr. Joanna Brewer
  • Chief Scientific Officer
  • --
  • David M. Mott
  • Chairman of the Board
  • 174.83K
  • Dr. Priti Hegde, PhD
  • Independent Director
  • 82.25K
  • Dr. Kristen M. Hege, M.D.
  • Independent Director
  • 72.63K
  • Dr. Garry E. Menzel, PhD
  • Independent Director
  • 117.29K
  • John P. Furey
  • Independent Director
  • 117.25K
  • Dr. Andrew R. Allen, M.D.,PhD
  • Independent Director
  • 83.50K
  • Lawrence M. Alleva
  • Independent Director
  • 128.80K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 111.54K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.